Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

10
Will Ultra Petroleum File For Bankruptcy Again As Stock Drops Over 90%

2018-08-13 seekingalpha - 4
Ultra Petroleum Corp (UPL) is in trouble. After exiting Ch.11 in April 2017, they still have way too much debt. Recently management announced problems with their expensive horizontal drilling and that they are selling their Utah oil assets for only $75 million, which they paid $650 million. The stock price has plunged from the Ch.11 estimated equity plan value for new UPL shares of $17.30 to only $1.
UPL REXX BBPPQ RXNRP REXXQ BBEP UPLMQ BBEPQ BBEPP

4
Ultra Petroleum Corp. (UPL) CEO Bradley Johnson on Q2 2018 Results - Earnings Call Transcript

2018-08-09 seekingalpha
Good day, everyone, and welcome to today's Ultra Petroleum Second Quarter 2018, Earnings Conference Call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] Please note this call is being recorded.
UPL UPLMQ MS

10
Coty, e.l.f Beauty Sink into Thursday’s 52-Week Low Club

2018-08-09 247wallst - 1
August 9, 2018: Here are four stocks trading with heavy volume among 96 equities making new 52-week lows in Thursday’s session. On the NYSE decliners and advancers traded even and on the Nasdaq, advancers led decliners by about 1.05 to 1.
ACAD UPL UPLMQ ELF COTY

4
Ultra Petroleum Corp. 2018 Q2 - Results - Earnings Call Slides

2018-08-09 seekingalpha
The following slide deck was published by Ultra Petroleum Corp. in conjunction with their 2018 Q2 earnings call.
UPL UPLMQ

30
Plug Power (PLUG) Reports Q2 Loss, Misses Revenue Estimates

2018-08-09 zacks
Plug Power (PLUG - Free Report) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.10 per share a year ago. These figures are adjusted for non-recurring items.
GD UPL BSTC UPLMQ PLUG

30
Ultra Petroleum (UPL) Misses Q2 Earnings and Revenue Estimates

2018-08-09 zacks
Ultra Petroleum (UPL - Free Report) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.28 per share a year ago. These figures are adjusted for non-recurring items.
GD UPL BSTC UPLMQ PLUG

30
BioSpecifics Technologies (BSTC) Q2 Earnings Top Estimates

2018-08-09 zacks
BioSpecifics Technologies (BSTC - Free Report) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.36 per share a year ago. These figures are adjusted for non-recurring items.
GD UPL BSTC UPLMQ PLUG

34
Agenus (AGEN) Reports Q2 Loss, Lags Revenue Estimates

2018-08-09 zacks
Agenus (AGEN - Free Report) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.32 per share a year ago. These figures are adjusted for non-recurring items.
GD UPL BSTC AGEN UPLMQ PLUG

30
Veritiv (VRTV) Lags Q2 Earnings Estimates

2018-08-09 zacks
Veritiv (VRTV - Free Report) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $0.88 per share a year ago. These figures are adjusted for non-recurring items.
GD UPL BSTC VRTV UPLMQ PLUG

5
Ultra Petroleum Announces Second Quarter 2018 Results, Provides Update on Horizontal and Vertical Program

2018-08-09 globenewswire - 1
HOUSTON, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Ultra Petroleum Corp. (NASDAQ: UPL) announces financial and operating results for the quarter ended June 30, 2018.
UPL UPLMQ

10
Murphy Oil (MUR) to Report Q2 Earnings: What's in the Cards?

2018-08-07 zacks
Murphy Oil Corporation (MUR - Free Report) is set to report second-quarter 2018 results, after market close on Aug 8. In the last reported quarter, the company posted a positive earnings surprise of 4.55%. Factors to Consider Murphy Oil has adopted capital investment initiatives to drive growth. The company expects second-quarter 2018 production in the range of 166,000 to 169,000 barrels of oil equivalents per day (boepd).
UPL CQP ODP LNG REI MUR.WI MUR UPLMQ AES

6
Portfolio PitFall #2: Holding Losers

2018-07-16 seekingalpha - 1
Superior returns are not solely achieved by finding massive winners, they're realized by letting go of the losers that are a drag on the portfolio.
SBGL.WI UPL UPLMQ TIS

70
Overview Of Some Recent Bankrupt Companies

2018-07-16 seekingalpha - 1
The effective recovery for "old" Ulra Petroleum shareholders has plunged to just a token $0.10 per share.
UPL BLT JCP BHPBF PJT WMLP WLBA XCOOQ SHLD XCO EGC BONTQ BHP SDRL BBL XCOO BHP UPLMQ BONT BHPLF

7
Implied Volatility Surging for Ultra Petroleum (UPL) Stock Options

2018-07-16 zacks
Investors in Ultra Petroleum Corp. (UPL - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 17, 2018 $2.50 Call had some of the highest implied volatility of all equity options today.
UPL GTT KRYS UPLMQ

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 903914109